NCM
CEMI

Nantahala Capital Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

Nantahala Capital Management’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-250,793
Closed -$815K – 133
2020
Q2 		$815K Sell
250,793
-1,181,239
-82% -$11.2M 0.02% 107
2020
Q1 		$7.33M Buy
1,432,032
+192,049
+15% +$777K 0.27% 59
2019
Q4 		$5.65M Hold
1,239,983
– – 0.17% 63
2019
Q3 		$7.59M Hold
1,239,983
– – 0.28% 60
2019
Q2 		$7.55M Buy
1,239,983
+89,983
+8% +$607K 0.23% 60
2019
Q1 		$6.38M Buy
1,150,000
+330,000
+40% +$2.14M 0.2% 67
2018
Q4 		$4.64M Buy
+820,000
New +$6.04M 0.14% 77

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Nantahala Capital Management's CEMI Position: Q3 2020 in Review

Nantahala Capital Management sold out of Chembio diagnostics, Inc. (CEMI) in Q3 2020, closing a stake of 250,793 shares — an estimated $815K sold.

Nantahala Capital Management first reported a position in CEMI in Q4 2018 and held it in 7 quarters. The position peaked at $7.59M in Q3 2019. 59 funds tracked by Wall St. Rank hold CEMI as of Q3 2020.

  • Nantahala Capital Management reported no remaining Chembio diagnostics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Nantahala Capital Management sold 250,793 Chembio diagnostics, Inc. shares in Q3 2020, an estimated $815K.
  • Nantahala Capital Management first reported a position in Chembio diagnostics, Inc. in Q4 2018 and held it in 7 quarters.
  • Nantahala Capital Management's Chembio diagnostics, Inc. position peaked at $7.59M in Q3 2019.
  • 59 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q3 2020.

Based on Nantahala Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.